Menu Search
Equities

Zhejiang Taimei Medical Technology Co Ltd

2576:HKG

Zhejiang Taimei Medical Technology Co Ltd

Actions
Health CareHealth Care Providers
  • Price (HKD)5.42
  • Today's Change-0.18 / -3.21%
  • Shares traded49.20k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 05:44 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Zhejiang Taimei Medical Technology Co Ltd grew revenues 4.36% from 549.22m to 573.14m while net income improved from a loss of 412.91m to a smaller loss of 346.78m.
Gross margin32.99%
Net profit margin-63.75%
Operating margin-70.55%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Zhejiang Taimei Medical Technology Co Ltd fell by 148.82m. However, Cash Flow from Investing totalled 237.69m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 351.16m for operations while cash used for financing totalled 39.28m.
Cash flow per share-0.605
Price/Cash flow per share--
Book value per share1.81
Tangible book value per share1.67
More ▼

Balance sheet in CNYView more

Zhejiang Taimei Medical Technology Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio4.46
Quick ratio--
Total debt/total equity0.0146
Total debt/total capital0.0133
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.